Company Performance Metrics
Franco Vitaliano: President & CEO
ExQor is going to be the premiere company in the field of health extension and central nervous system.
In one example, ExQor is using its multi-patented bio-nanotechnology to develop a new type of treatment for Alzheimer's disease and that could be efficaciously used at any stage of the disease, including years before symptoms develop.
Another example is a drug being developed for treating HIV-associated neurocognitive disorders (HAND).
And a third drug is under development for treating drug addiction.
These developments are all funded by US National Institutes of Health.
ExQor is also developing a drug to treat HER2 positive brain metastases through non-invasive delivery of trastuzumab or a biosimilar. The work is being done in cooperation with the US National Institutes of Health.
